X

Health Care

Cara Therapeutics’ (CARA) loss expands in Q3 on higher costs

Cara Therapeutics' (NASDAQ: CARA) loss widened in the third quarter of 2019, hurt by higher expenses. Cara Therapeutics posted a…

Viking Therapeutics (VKTX): Q3 2019 Earnings Snapshot

-- Viking Therapeutics Inc. (NASDAQ: VKTX) reported Q3 2019 loss of $0.08 per share, vs. a loss of $0.13 expected.…

Allergan (NYSE: AGN) Q3 loss widens but beats estimates

Allergan plc (NYSE: AGN) reported a wider loss in the third quarter of 2019 due to the divestitures, products that…

Intercept Pharmaceuticals posts Q3 miss, stock slips

Intercept Pharmaceuticals (NASDAQ: ICPT) on Tuesday reported third-quarter results that missed Wall Street expectations, but raised its guidance for the…

Mylan (MYL) Q3 earnings surpass estimates; revenues miss

Drugmaker Mylan (NASDAQ: MYL) reported third-quarter revenues that fell short of expectations. Meanwhile, earnings increased and surpassed the consensus estimate.…

Regeneron Pharmaceuticals (NASDAQ: REGN): Q3 2019 Earnings Snapshot

-- Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third-quarter 2019 adjusted earnings of $6.67 per share versus $6.36 per share…

Endo International (ENDP): Q3 2019 Earnings Snapshot

-- Endo International plc (NASDAQ: ENDP) reported Q3 2019 earnings of $0.60 per share, vs. $0.53 expected. -- Revenues fell…

Mallinckrodt plc (MNK): Q3 2019 Earnings Snapshot

--  Mallinckrodt plc (NYSE: MNK) reported third-quarter 2019 earnings of $2.07 per share, vs. $1.97 per share expected. -- Revenue…

Amarin’s Q3 results top estimates

Amarin Corporation plc (NASDAQ: AMRN) reported better-than-expected revenue and earnings for the third quarter of 2019, allowing the stock to…

Allscripts (NASDAQ: MDRX): Q3 2019 Earnings Snapshot

-- Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) reported its third-quarter 2019 adjusted earnings of $0.17 per share and GAAP loss…